GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University PRESS RELEASE: JULY 15, 2020Albuquerque, NM – GPER G-1 Development Group, a portfolio company of the New Mexico Start-Up Factory, is developing a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the […]
Category: Treatment
GPER G-1 Technology is Published in Renowned Medical Journal
We are proud to announce that the novel technology licensed by GPER G-1 Development Group, a New Mexico Start-Up Factory II Portfolio Company, has recently been published by Science Translational Medicine and the American Association for the Advancement of Science (AAAS). GPER-G-1 is a drug development company with the primary goal of advancing novel drug candidates […]